Toxicity after moderately hypofractionated versus conventionally fractionated prostate radiotherapy: A systematic review and meta-analysis of the current literature-Reference-Cited by-同舟云学术

Toxicity after moderately hypofractionated versus conventionally fractionated prostate radiotherapy: A systematic review and meta-analysis of the current literature

Published:2021-09 Issue: Volume:165 Page:103432
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Francolini G.^ORCID,Detti B.,Becherini C.,Caini S.,Ingrosso G.,Di Cataldo Vanessa,Stocchi G.,Salvestrini V.,Lancia A.^ORCID,Scartoni D.,Giacomelli I.,Sardaro A.,Carbonara R.,Borghesi S.,Aristei C.,Livi L.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference20 articles.

1. Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority, phase 3 trial;Aluwini;Lancet Oncol. [Internet],2016

2. A Prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high-risk prostate cancer;Arcangeli;Int. J. Radiat. Oncol. Biol. Phys.,2010

3. Acute and late toxicity in a randomized trial of conventional versus hypofractionated three-dimensional conformal radiotherapy for prostate cancer;Arcangeli;Int. J. Radiat. Oncol. Biol. Phys.,2011

4. Moderate hypofractionation in high-risk, organ-confined prostate cancer: final results of a phase III randomized trial;Arcangeli;J. Clin. Oncol.,2017

5. Estimates of Alpha/Beta (α/β) ratios for individual late rectal toxicity endpoints: an analysis of the CHHiP trial;Brand;Int. J. Radiat. Oncol. Biol. Phys.,2021

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Image-guided moderately hypofractionated radiotherapy for localized prostate cancer: a multicentric retrospective study (IPOPROMISE);La radiologia medica;2024-02-19

2. Clinical Guidelines for the Prevention and Treatment of Radiation‐induced Bladder Injury;Precision Radiation Oncology;2024-02-08

3. High-risk prostate cancer treated with a stereotactic body radiation therapy boost following pelvic nodal irradiation;Frontiers in Oncology;2024-02-06

4. Assessment of bladder filling during prostate cancer radiation therapy with ultrasound and cone-beam CT;Frontiers in Oncology;2023-07-27

5. Hypofractionated Radiotherapy in Localized, Low–Intermediate-Risk Prostate Cancer: Current and Future Prospectives;Medicina;2023-06-14